XNW5004 Tablets

· Evopoint Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XNW5004 Tablets, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma [Phase 2]